AI & Emerging Technology

Amai Proteins' sweelin® just got a major scientific boost. New clinical data in a top journal proves its metabolic safety, fast-tracking its commercial journey.

IBM's free SkillsBuild AI pathway aims to upskill the UK workforce from entry-level to C-suite, fueling national competitiveness and commercial AI adoption.

With its new SmartBioSurface slides, Italian firm Tethis aims to solve a major lab challenge. The key? A nanotech surface that could reshape disease research.

At a key industry summit, Camel Energy unveiled a dual battery strategy for Europe, pairing advanced lithium-ion with disruptive sodium-ion technology.

Agoda is selling serenity by promoting Asia's 'hidden' retreats. But as the wellness travel market booms, what is the true cost for these fragile destinations?

At Shanghai's CHINA CYCLE expo, CST Tires unveiled more than just lightweight tech; it showcased a strategic pivot that could redefine global manufacturing.

A small biotech is about to reveal data on a novel drug that could change autoimmune care. Will its bold scientific strategy pay off for patients and investors?

A new alliance between General Fluidics and Invetech seeks to move lab testing from centralized facilities to the clinic, promising faster, more accessible care.

A new open standard called Aliro, backed by industry giants, is set to revolutionize access control, promising a future free from proprietary walled gardens.

Skeeter's new FXE bass boat is more than a product launch; it's a calculated play in manufacturing precision and market strategy amid shifting economic tides.

PATTISON Outdoor's new PULSE platform, powered by 20 billion data points, promises a new era of precision for transit and airport advertising.

Canada's new 'AI for All' strategy bets billions on sovereign compute and closing its adoption gap. Can this ambitious plan build a uniquely Canadian AI future?

Set to join the Russell 3000, Starfighters Space and its unique F-104 fleet bring Wall Street's focus to a new class of aerospace infrastructure.

ALLSWIFIT's new Stedi Collection challenges the 'soft is best' mantra, betting that true all-day comfort comes from biomechanical support, not just cushioning.

As titans clash for the World Cup betting market, The Sports Geek unveils a new playbook focusing on data, niche audiences, and the staggering cost of fandom.

A new drug promises the brain-rewiring benefits of psychedelics without the trip. Can Clearmind Medicine's CMND-100 transform addiction treatment?

AMZFAST is no longer just a gaming brand. Its Computex 2026 lineup targets every screen in your life, from 400Hz esports to Google TV-powered smart displays.

Behind billion-dollar antitrust settlements are silent administrators. A look at how one firm, A.B. Data, has dominated for eight years straight.

Drucker + Falk's new CPO and Chief of Staff roles aren't just promotions; they're a blueprint for scaling a legacy firm under new private equity ownership.

A new alliance between Made Scientific and Pluristyx promises to slash the time and cost of developing advanced iPSC therapies. But can it deliver on its promise?